Roivant Sciences (ROIV) shares outstanding: 724.6M
Roivant Sciences had 724.6M shares outstanding on Nov 3, 2026, up 4.2% from 695.5M a year earlier.
From Roivant Sciences's filings with the SEC · ROIV stock page
Roivant Sciences shares outstanding by year
#163 of 3,715 US companies by shares outstanding · See the full ranking
| Year ended | Shares outstanding | Change |
|---|---|---|
| Nov 3, 2026 | 724.6M | +4% |
| Nov 3, 2025 | 695.5M | -4% |
| Nov 8, 2024 | 727.9M | -9% |
| Nov 9, 2023 | 803.9M | +11% |
| Nov 10, 2022 | 725.4M | – |
Shares outstanding of similar companies
Companies in the same industry as Roivant Sciences, by SEC industry code, with the closest shares outstanding. Each name opens the same page for that company.
| Company | Shares outstanding, latest year | Year ended |
|---|---|---|
| Viatris | 1.15B | Nov 2, 2026 |
| Eli Lilly | 940.7M | Oct 26, 2026 |
| HUTCHMED (China) | 872.3M | Dec 31, 2025 |
| Summit Therapeutics | 799.8M | Oct 30, 2026 |
| Opko Health | 742.5M | Oct 20, 2026 |
| Roivant Sciences | 724.6M | Nov 3, 2026 |
| Elanco Animal Health | 499.8M | Nov 4, 2026 |
Questions and answers
What is Roivant Sciences's shares outstanding?
Roivant Sciences had 724.6M shares outstanding on Nov 3, 2026, up 4.2% from 695.5M a year earlier.
Numbers as reported in Roivant Sciences's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology